Anti-PRAS40 antibody [EPR6402]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(0 Publication)
Rabbit Recombinant Monoclonal PRAS40 antibody. Suitable for WB and reacts with Human, Mouse, Rat samples.
View Alternative Names
PRAS40, AKT1S1, Proline-rich AKT1 substrate 1, 40 kDa proline-rich AKT substrate
- WB
Unknown
Western blot - Anti-PRAS40 antibody [EPR6402] (AB133584)
All lanes:
Western blot - Anti-PRAS40 antibody [EPR6402] (ab133584) at 1/1000 dilution
Lane 1:
MCF7 cell lysate at 10 µg
Lane 2:
L6 cell lysate at 10 µg
Lane 3:
C6 cell lysate at 10 µg
Lane 4:
RAW 264.7 cell lysate at 10 µg
Lane 5:
PC12 cell lysate at 10 µg
Lane 6:
NIH 3T3 cell lysate at 10 µg
Lane 7:
293T cell lysate at 10 µg
Lane 8:
HeLa cell lysate at 10 µg
Secondary
All lanes:
HRP labelled Goat anti-Rabbit IgG at 1/2000 dilution
Predicted band size: 27 kDa
false
- WB
Lab
Western blot - Anti-PRAS40 antibody [EPR6402] (AB133584)
Lanes 1 - 4 : Merged signal (red and green). Green - ab133584 observed at 40 kDa. Red - loading control, ab130007, observed at 125 kDa.
ab133584 was shown to specifically react with PRAS40 in wild-type HAP1 cells as signal was lost in AKT1S1 (PRAS40) knockout cells. Wild-type and AKT1S1 (PRAS40) knockout samples were subjected to SDS-PAGE. ab133584 and ab130007 (Mouse anti-Vinculin loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-PRAS40 antibody [EPR6402] (ab133584) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
AKT1S1 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HeLa whole cell lysate at 20 µg
Lane 4:
MCF-7 whole cell lysate at 20 µg
Predicted band size: 27 kDa
Observed band size: 40 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-PRAS40 antibody [EPR6402] (AB133584)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (1)
-
Anti-PRAS40 antibody [EPR6402] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PRAS40 acts as an inhibitory regulator in cellular growth and metabolism. PRAS40 is a part of the mTORC1 complex where it connects with other proteins to modulate the actions of mTOR a central regulator of cellular metabolism. By interacting with the mTORC1 complex PRAS40 can control protein synthesis and cell cycle progression. Furthermore PRAS40 responds to various cellular signals actively contributing to balancing growth factors and nutritional signals in cells.
Pathways
PRAS40 plays a significant role in the mTOR signaling pathway a critical pathway for cell growth and metabolism. PRAS40 regulation within this pathway involves the Akt protein which phosphorylates and modulates PRAS40 activity. Additionally PRAS40 has a connection to insulin signaling pathways where it impacts glucose uptake and energy homeostasis. Through interactions in these pathways PRAS40 balances cellular responses to growth factors and metabolic conditions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com